Niva Bupa Q4 Profit ₹345 Cr; Annual Revenue Up 21.59%, Tax Bill Looms

INSURANCE
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Niva Bupa Q4 Profit ₹345 Cr; Annual Revenue Up 21.59%, Tax Bill Looms
Overview

Niva Bupa Health Insurance posted a ₹345 crore profit for Q4 FY26, supported by 21.59% annual revenue growth to ₹6,473 crore. Despite clean audits and strong top-line expansion, a ₹127 crore tax demand under appeal and a lower annual profit compared to the quarterly result are key concerns for investors.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Niva Bupa Reports Strong Q4 Profit, But Tax Dispute Looms

Niva Bupa Health Insurance announced a robust profit after tax of ₹345.13 crore for the fourth quarter of fiscal year 2026. The company's total income for the quarter reached ₹2,077.66 crore, marking significant year-over-year growth.

Key Financial Highlights

For the full fiscal year FY26, Niva Bupa reported a standalone total income increase of 21.59%, reaching ₹6,473.67 crore. However, the standalone profit after tax for the entire fiscal year stood at ₹130.78 crore. This annual profit figure is substantially lower than the profit reported for the final quarter alone, a contrast that investors are expected to scrutinize.

Investor Focus: Tax Liability and Growth

Despite strong top-line expansion and clean audit reports, a contingent liability of ₹127.16 crore from an income tax demand under appeal remains a significant point for investors. The company's net worth strengthened to ₹3,218.97 crore in FY26, providing a financial buffer. Operational costs also stayed within regulatory limits, with the expenses of management ratio at 33.70%, supporting sustainable growth.

Company Background and Market Position

Niva Bupa Health Insurance, previously known as Max Bupa, underwent a rebranding after Bupa acquired a majority stake in late 2021 or early 2022. The company has focused on digital transformation and expanding its product offerings within the competitive Indian health insurance market.

Peer Landscape

Competitor Star Health reported higher annual profitability in FY25 despite a larger revenue base, indicating different profit margin structures. Larger general insurers like ICICI Lombard and HDFC ERGO operate at substantial scale, but Niva Bupa's growth in its specialized health segment is noteworthy.

What to Watch Next

Investors will be closely monitoring the outcome of the ₹127.16 crore income tax appeal. Management's commentary on the lower annual profit for FY26 compared to the Q4 results will also be crucial. Further progress on the company's digital initiatives and new product launches will be key indicators of future growth.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.